|
The NKDEP Laboratory Working Group was created to review and address the problems related to serum creatinine measurement for estimating GFR and to prepare recommendations to standardize and improve creatinine measurement.
The members of the NKDEP Laboratory Working Group listed below represent a cross section of some of the leading experts in relevant fields.
Members
Greg Miller, PhD Working Group Chair
Director, Pathology Information System
Co-Director, Clinical Chemistry
Virginia Commonwealth University
Edward Ashwood, MD
Professor of Pathology
Chief Medical Officer/Laboratory Director
University of Utah
Joris Delanghe, PhD
Department of Clinical Chemistry
University Hospital Ghent
John Eckfeldt, MD, PhD
Professor and Vice Chair for Clinical Affairs
Department of Laboratory Medicine & Pathology
University of Minnesota
James Fleming, PhD, FACB
Vice President and Director, Scientific Affairs
Department of Science and Technology
Laboratory Corporation of America
Neil Greenberg, PhD
Manager, Regulatory Affairs
Ortho Clinical Diagnostics
Glen Hortin, MD, PhD
Chief of Clinical Chemistry
Department of Laboratory Medicine
NIH Clinical Center
Thomas Hostetter, MD
Former Director
National Kidney Disease Education Program
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Chandra P. Jain, MS
American Association for Clinical Chemistry
Harvey Kaufman, MD
Medical Director, Business Development
Quest Diagnostics
Anthony Killeen, MD, PhD
Associate Professor, Laboratory Medicine and Pathology
University of Minnesota
David A. Lacher, MD, MEd
Research Medical Officer
CDC/National Center for Health Statistics
Andrew Levey, MD
Chief, Division of Nephrology
Dr. Gerald J. and Dorothy R. Friedman Professor of Medicine
Tufts-New England Medical Center
Leigh Ann Milburn, PharmD, BCPS
Clinical Pharmacy Specialist
Saint Luke's Hospital
Gary Myers, PhD
Chief, Clinical Chemistry Branch
Centers for Disease Control and Prevention
Andrew S. Narva, MD
Director
National Kidney Disease Education Program
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Mauro Panteghini, MD
Clinical Pathologist
Cattedra di Biochimica Clinica e Biologia Molecolare Clinica
Karen Phinney, PhD
Analytical Chemistry Division
National Institute of Standards and Technology
Max Robinowitz, MD
Medical Officer-Pathologist
Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiologic Health
US Food and Drug Administration
David W. Seccombe, MD, PhD, FRCPC
Managing Director
Canadian External Quality Assessment Laboratory (CEQAL)
Meeting Summaries
July 30, 2008 - Lab Meeting
This meeting provided an update on urine albumin activities and status reports on the revised pediatric equation and activities of NKDEP's working group addressing pharmacy issues.
July 17, 2007 - Lab Meeting (PDF, 59K)
This meeting addressed standardization in urine albumin measurement and reporting, whole blood creatinine measurement, creatinine specificity issues, and creatinine measurement for non-adults.
May 3, 2007 - Lab Meeting (PDF, 64K)
March 27-28, 2007 - Urine Albumin Meeting (PDF, 206K)
November 7, 2006 - Lab Meeting (PDF, 65K)
July 27, 2006 - Lab Meeting (PDF, 66K)
This meeting discussed the Creatinine Standardization Program's implications for pharmacy practice, pediatrics, and whole blood device manufacturers. Below is the presentation that was given at the meeting.
May 22, 2006 - Lab Meeting (PDF, 57K)
October 25, 2005 - Lab Meeting (PDF, 57K)
July 28, 2005 - Lab Meeting (PDF, 92K)
This meeting provided a status update on the revised estimating equation and included a discussion regarding the development of an implementation plan for rolling out the equation to laboratories, manufacturers and providers. Below are the presentations that were given.
March 11, 2005 - Lab Meeting (PDF, 104K)
To request meeting summaries for meetings prior to 2005, please email NKDEP.
In Vitro Manufacturers' Forums
July 30, 2008 - Forum Meeting
This meeting provided updates on creatinine standardization activities, activities of the working group addressing urine albumin, and activities of the Cystatin C Standardization Working Group (IFCC-EU); the latest on a proposed creatinine specificity study; and a review of revised pediatric content for the NKDEP website.
July 17, 2007 - Forum Meeting (PDF, 49K)
Meeting description and presentations are available under July 17, 2007
Lab Meeting.
July 27, 2006 - Forum Meeting (PDF, 44K)
This meeting reviewed the implications of the Creatinine Standardization Program for the IVD industry. Below are the presentations that were given at the meeting.
March 11, 2005 - Forum Meeting (PDF, 104K)
This forum reviewed recommendations for creatinine standardization and solicited feedback on the timing and process for the rollout of this initiative and new estimating equations. Below are the presentations that were given at the meeting.
To request meeting summaries for meetings prior to 2005, please email NKDEP.
PDF files require Adobe Acrobat.
|
